| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, Marchioninistraße 25, D-81377 München, Germany
The viral latent membrane proteins 2 (LMP2) of Epstein—Barr virus (EBV) were analysed genetically to evaluate their role in B cell immortalization. LMP2 is transcribed as two differently spliced mRNAs which code for the LMP2A and -B proteins, also called terminal protein-1 and -2. LMP2A and -B are found in latently infected, growth-transformed B lymphocytes in vitro, in different human tumours, and in latently infected B cells in vivo. Two different approaches were used to generate EBV mutants in which the second, third and part of the fourth exon of the LMP2 gene were deleted by insertion of a marker gene. Initially, conventional homologous recombination in a Burkitt's lymphoma cell line (P3HR1) between the endogenous EBV genome and an introduced plasmid was used to generate EBV mutants. This experiment identified LMP2 as dispensable for B cell immortalization as has been reported. In a second approach, the same LMP2 mutant gene was analysed in the context of a mini-EBV plasmid. These are E. coli constructs that are sufficient when packaged into an EBV coat both to initiate and to maintain proliferation of infected B cells. In comparison with a fully competent mini-EBV, LMP2- mini-EBVs were found to be greatly reduced in their capacity to yield immortalized B cell clones. This finding confirmed the initially observed bias against LMP2- B cell clones, most of which were found to be coinfected with complementing P3HR1 virus. These results indicate that LMP2 contributes to the efficiency of B cell immortalization and that the LMP2s phenotype is auxiliary in nature.
Received 7 May 1996;
accepted 5 July 1996.
This article has been cited by other articles:
|
|
 |
|
  I. Guasparri, D. Bubman, and E. Cesarman EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression Blood, April 1, 2008; 111(7): 3813 - 3820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Gordadze, D. Poston, and P. D. Ling The EBNA2 Polyproline Region Is Dispensable for Epstein-Barr Virus-Mediated Immortalization Maintenance J. Virol., June 14, 2002; 76(14): 7349 - 7355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Konishi, S. Maruo, H. Kato, and K. Takada Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation J. Gen. Virol., June 1, 2001; 82(6): 1451 - 1456. [Abstract] [Full Text]
|
|
|
|
 |
|
 K J Flavell and P G Murray Hodgkin's disease and the Epstein-Barr virus Mol. Pathol., October 1, 2000; 53(5): 262 - 269. [Abstract] [Full Text]
|
|
|
|
|
|
H-J Delecluse and W Hammerschmidt The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy Mol. Pathol., October 1, 2000; 53(5): 270 - 279. [Abstract] [Full Text]
|
|
|
|
|
|
L. J. Strobl, H. Höfelmayr, G. Marschall, M. Brielmeier, G. W. Bornkamm, and U. Zimber-Strobl Activated Notch1 Modulates Gene Expression in B Cells Similarly to Epstein-Barr Viral Nuclear Antigen 2 J. Virol., February 15, 2000; 74(4): 1727 - 1735. [Abstract] [Full Text]
|
|
|
|
|
|
P. Speck, K. A. Kline, P. Cheresh, and R. Longnecker Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus J. Gen. Virol., August 1, 1999; 80(8): 2193 - 2203. [Abstract] [Full Text]
|
|
|
|
 |
|
 H.-J. Delecluse, T. Hilsendegen, D. Pich, R. Zeidler, and W. Hammerschmidt Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells PNAS, July 7, 1998; 95(14): 8245 - 8250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Tao, K. D. Robertson, A. Manns, A. Hildesheim, and R. F. Ambinder Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue Blood, February 15, 1998; 91(4): 1373 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Niedobitek, E. Kremmer, H. Herbst, L. Whitehead, C.W. Dawson, E. Niedobitek, C. von Ostau, N. Rooney, F.A. Grasser, and L.S. Young Immunohistochemical Detection of the Epstein-Barr Virus-Encoded Latent Membrane Protein 2A in Hodgkin's Disease and Infectious Mononucleosis Blood, August 15, 1997; 90(4): 1664 - 1672. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
